Baird Financial Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-16,270
| Closed | -$140K | – | 1743 |
|
|
2022
Q3 | $140K | Sell |
16,270
-134
| -0.8% | -$1.15K | ﹤0.01% | 1646 |
|
|
2022
Q2 | $134K | Buy |
16,404
+111
| +0.7% | +$907 | ﹤0.01% | 1730 |
|
|
2022
Q1 | $198K | Sell |
16,293
-465
| -3% | -$5.65K | ﹤0.01% | 1755 |
|
|
2021
Q4 | $571K | Buy |
16,758
+2,701
| +19% | +$92K | ﹤0.01% | 1419 |
|
|
2021
Q3 | $678K | Buy |
14,057
+245
| +2% | +$11.8K | ﹤0.01% | 1354 |
|
|
2021
Q2 | $624K | Buy |
13,812
+457
| +3% | +$20.6K | ﹤0.01% | 1342 |
|
|
2021
Q1 | $644K | Sell |
13,355
-454
| -3% | -$21.9K | ﹤0.01% | 1285 |
|
|
2020
Q4 | $743K | Sell |
13,809
-310
| -2% | -$16.7K | ﹤0.01% | 1117 |
|
|
2020
Q3 | $521K | Sell |
14,119
-4,162
| -23% | -$154K | ﹤0.01% | 1140 |
|
|
2020
Q2 | $566K | Buy |
18,281
+7,159
| +64% | +$222K | ﹤0.01% | 1115 |
|
|
2020
Q1 | $307K | Sell |
11,122
-36
| -0.3% | -$994 | ﹤0.01% | 1204 |
|
|
2019
Q4 | $326K | Buy |
11,158
+140
| +1% | +$4.09K | ﹤0.01% | 1296 |
|
|
2019
Q3 | $211K | Buy |
11,018
+265
| +2% | +$5.08K | ﹤0.01% | 1429 |
|
|
2019
Q2 | $236K | Buy |
+10,753
| New | +$236K | ﹤0.01% | 1415 |
|